Skip to content

DilaCheck Cervical Dilation Measurement Trial

Inter-examiner Agreement of a Novel Device for the Measurement of Cervical Dilation in Labor: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03440723
Enrollment
42
Registered
2018-02-22
Start date
2020-01-06
Completion date
2020-03-30
Last updated
2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Dilation, Labor Fast, Labor; Irregular, Labor Pain

Keywords

Cervical Dilation, Dilation, Sterile vaginal examination

Brief summary

Trial to compare the interexaminer agreement between two cervical dilation examinations conducted by Labor and Delivery physicians when using standard methods versus DilaCheck device.

Detailed description

The trial seeks to compare the DilaCheck device with standard digital cervical dilation examinations. 50 laboring female participants will be enrolled with 25 randomly assigned to the control arm and 25 to the treatment (DilaCheck) arm. Each participant will receive two cervical dilation examinations from two separate physicians. The main outcome measure is agreement between the two cervical dilation measurements. Secondary outcomes include ease of use of the device and pain levels.

Interventions

DEVICEDilaCheck

Measuring device for the measurement of cervical dilation

DIAGNOSTIC_TESTCervical dilation examination

Sterile vaginal examination using subjective methods for measurement of cervical dilation

Sponsors

Thomas Jefferson University
CollaboratorOTHER
Elm Tree Medical Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Masking description

Masking is not possible since physicians and participants will know whether they are using the device or not.

Intervention model description

Randomized controlled trial in which participants are randomly assigned to one of two arms, control or treatment

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The research population is pregnant women in the first stage of labor. Subjects eligible for inclusion in the study must be: pregnant women who are admitted to a Labor and Delivery unit for management or induction of labor in the first stage of labor, are able to give informed consent, are 18 years of age or greater, speak English, and have a gestational age greater than or equal to 37 weeks (i.e. term pregnancy). Patients are only consented if they have adequate pain control, either because they are not yet in labor (i.e. are admitted for an induction of labor) or have a functioning epidural.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Interexaminer AgreementImmediate upon examinationAgreement between 2 cervical dilation measurements taken by 2 different physicians. If the measurements are the same, the outcome is agree. If the measurements are different, the outcome is disagree.

Secondary

MeasureTime frameDescription
Pain With ExaminationImmediate within 5 minutes of examinationsScores on a Scale. Subjective experience of pain during dilation examinations as measured by scores on a scale given to patient participants following the cervical dilation examinations. The pain measurement is a scale of 1 to 10 with 1 being no pain and 10 being extreme pain. The participant enters a number from 1 to 10 on the survey.
Ease of UseUpon conclusion of the trial, <3 months from time of last examination with deviceEase of Use of the device as reported by physician users on a paper survey administered to them. Reported is number of physicians who reported device is easy to use.

Countries

United States

Participant flow

Recruitment details

Recruitment finalized at 42 due to COVID

Participants by arm

ArmCount
Standard Dilation Exam
Participants receive two standard digital cervical dilation examinations conducted by two different physicians. Cervical dilation examination: Sterile vaginal examination using subjective methods for measurement of cervical dilation
21
Dilation Exam With DilaCheck
Participants receive two cervical dilation examinations using DilaCheck devices conducted by two different physicians. DilaCheck: Measuring device for the measurement of cervical dilation
21
Total42

Baseline characteristics

CharacteristicStandard Dilation ExamTotalDilation Exam With DilaCheck
Age, Continuous26.8 years
STANDARD_DEVIATION 5
28 years
STANDARD_DEVIATION 5.3
29.1 years
STANDARD_DEVIATION 5.6
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants5 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
18 Participants37 Participants19 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants4 Participants4 Participants
Race (NIH/OMB)
Black or African American
15 Participants24 Participants9 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
6 Participants13 Participants7 Participants
Region of Enrollment
United States
21 Participants42 Participants21 Participants
Sex: Female, Male
Female
21 Participants42 Participants21 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 210 / 21
other
Total, other adverse events
0 / 210 / 21
serious
Total, serious adverse events
0 / 210 / 21

Outcome results

Primary

Interexaminer Agreement

Agreement between 2 cervical dilation measurements taken by 2 different physicians. If the measurements are the same, the outcome is agree. If the measurements are different, the outcome is disagree.

Time frame: Immediate upon examination

Population: All enrollees

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard Dilation ExamInterexaminer Agreement9 Participants
Dilation Exam With DilaCheckInterexaminer Agreement4 Participants
Secondary

Ease of Use

Ease of Use of the device as reported by physician users on a paper survey administered to them. Reported is number of physicians who reported device is easy to use.

Time frame: Upon conclusion of the trial, <3 months from time of last examination with device

Population: All providers who participated in the trial completed the survey

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard Dilation ExamEase of Use7 Participants
Secondary

Pain With Examination

Scores on a Scale. Subjective experience of pain during dilation examinations as measured by scores on a scale given to patient participants following the cervical dilation examinations. The pain measurement is a scale of 1 to 10 with 1 being no pain and 10 being extreme pain. The participant enters a number from 1 to 10 on the survey.

Time frame: Immediate within 5 minutes of examinations

Population: all enrollees

ArmMeasureValue (MEAN)Dispersion
Standard Dilation ExamPain With Examination2.8 score on pain scaleStandard Deviation 2.8
Dilation Exam With DilaCheckPain With Examination3.1 score on pain scaleStandard Deviation 2.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026